Actively Recruiting

Age: 18Years +
FEMALE
NCT06229522

Patients Derived Organoids as a Promising Tool to Tailor Ovarian Cancer Therapies (PANDORA).

Led by Centro di Riferimento Oncologico - Aviano · Updated on 2024-01-29

150

Participants Needed

1

Research Sites

737 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The association of clinical, pathogenesis and mutational profile of patients affected by ovarian cancer have improved the armamentarium of therapies available for medical doctors. One of most remarkable advancements is represented by the introduction of PARP inhibitors in the front-line setting of advanced ovarian carcinoma. It is necessary to continue with this effort and introduce novel approaches to improve the survival rate as well as predictive biomarkers to approved therapies. Given the absence of predictive biomarkers to standard therapy, patients derived organoid could be a promising platform to test clinically available drugs and/or promising new molecules to explore the tumor sensibility in an ex-vivo model. The aim of this study is to correlate treatment sensibility measured in tumor derived organoids to clinical sensibility seen in real world patients.

CONDITIONS

Official Title

Patients Derived Organoids as a Promising Tool to Tailor Ovarian Cancer Therapies (PANDORA).

Who Can Participate

Age: 18Years +
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Signed informed consent form
  • Female sex
  • Age 18 years or older
  • Diagnosis of ovarian cancer
  • Availability of tumor sample or ascites planned for storage in the Institutional Biobank for research
Not Eligible

You will not qualify if you...

  • Tumor or ascites biobanking process that could compromise diagnostic assessments
  • Pregnancy or breastfeeding
  • History of another malignancy within the last 5 years

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Centro di Riferimento Oncologico (CRO) di Aviano - IRCCS

Aviano, Pordenone, Italy, 33081

Actively Recruiting

Loading map...

Research Team

V

Vincenzo Canzonieri, MD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here